Cargando…
Impact of DNA Damage Response—Targeted Therapies on the Immune Response to Tumours
SIMPLE SUMMARY: Targeting tumour-specific defects in the DNA damage response (DDR) presents an opportunity for new therapeutic approaches to selectively kill cancer cells. Although the therapeutic rationale of DDR-targeted agents initially focused on their actions against tumour cells, these agents...
Autores principales: | Lutfi, Nura, Galindo-Campos, Miguel Alejandro, Yélamos, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656491/ https://www.ncbi.nlm.nih.gov/pubmed/34885119 http://dx.doi.org/10.3390/cancers13236008 |
Ejemplares similares
-
Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
por: Huang, Jau-Ling, et al.
Publicado: (2022) -
Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023) -
Targeting DNA damage response in cancer therapy
por: Hosoya, Noriko, et al.
Publicado: (2014) -
Targeting the DNA damage response for cancer therapy
por: Curtin, Nicola J.
Publicado: (2023) -
DNA Damage Response and Immune Defense
por: Nastasi, Claudia, et al.
Publicado: (2020)